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TECHNICAL NOTE
Intrarenal nitric oxide monitoring with a Clark-type electrode:
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Nitric oxide (NO) exerts profound effects on renal physiology
[1—41. Renal NO generation occurs in endothelial cells by the
constitutive isoform of nitric oxide synthase (cNOS) and in
macrophages, smooth muscle and mesangial cells by the inducible
isoform (iNOS). The former system plays an important role in
basal renal vascular tone and hemodynamic regulation, in mesan-
gial contraction, renin release and tubuloglomerular feedback.
The inducible NOS, widely distributed in the rat kidney, pre-
dominantly in the outer medulla and in cortical glomeruli [5],
counterbalances vasoconstrictive, thrombogenic and proliferative
stimuli associated with cytokine stimulation and inflammatory
responses [6].
Intact nitrovasodilation is particularly important at the outer
medulla, where tissue oxygen tension as low as 30 mm Hg
normally exists [7]. Inhibition of NOS results in profound renal
hypoperfusion, both at the cortex and outer medulla [8, 9],
associated with substantial aggravation of medullary hypoxia [10].
Blockade of NO synthesis potentiates medullary hypoxic injury
from radiocontrast and non-steroidal anti-inflammatory agents
[9—111 and augments medullary hypoperfusion and damage dur-
ing acute ureteral obstruction [121.
Recently developed Clark-type selective NO microelectrodes
enable real-time monitoring of NO concentrations in vitro in cell
lines and incubated tissues [13—17], in organs maintained ex vivo
[18] or in the living organism [19, 20]. With concomitant deter-
mination of intrarenal blood flow it could be a potent experimen-
tal tool for the evaluation of the role of NO in renal hemodynam-
ics. In preliminary studies with the NO electrode, a paradoxical
increase in medullary NO reading was noted following NOS
inhibition. This led us to evaluate potential artifacts of NO
monitoring, such as fluctuations in tissue oxygenation (since
oxygen and reactive oxygen species scavenges NO with the
production of NO2/NO3 , not sensed by the electrode) and
temperature (which markedly affect the electrode current) [21].
Methods
In vivo experiments
Male Sprague-Dawley rats (mean weight of 352 grams) were
used for all experiments, anesthetized with mactin (100 mg/kg
body wt; BYK Gulden, Konstanz, Germany). Tracheotomy was
done and the femoral vein and artery were cannulated with PE5O
catheters (Clay-Adams, Parsippany, NJ, USA), for drug adminis-
tration and for the monitoring of blood pressure. Another poly-
ethylene tube was inserted into the right external jugular vein for
intravenous hydration. Saline supplemented with 4% bovine-
serum albumin was infused at a rate of 0.16 ml/min. Mean blood
pressure was recorded with the use of a calibrated pressure
transducer and monitor (Hewlett-Packard Inc., Sunnyvale, CA,
USA), connected to the femoral arterial line.
The left kidney was exposed by a mid-abdominal incision and
mechanically fixed. Its capsule was gently removed from the
anterior aspect. The temperature of the kidney was monitored by
a needle copper probe, connected to a type T thermocouple
(Omega Engineering, Stamford, CT, USA). Rectal and renal
temperatures were kept at 37 to 38°C with a heating lamp and
dripping warm saline and mineral oil.
Flow measurements
Renal blood flow was monitored by a perivascular transonic
ultrasonic volume flow sensor (T-106; Transonic Systems Inc.,
Ithaca, NY, USA), with the probe mounted on the left renal
artery. Medullary blood flow was measured by laser-Doppler
probe connected to flowmeter (model PF2B; Perimed, Stock-
holm, Sweden). As previously reported [8, 9, 12], a needle probe
(0.45 mm diameter), mounted on a micromanipulator was in-
serted at a depth of 4.5 to 5.5 mm, for the determination of
changes in outer medullasy blood flow.
NO measurements
The NO detection system (Model NO-Sot; Inter Medical,
Tokyo, Japan), is a porphyrinic-based microsensor [17, 21] con-
sisted of a working electrode and a counter electrode made of
carbon fiber. The working electrode is made of Pt/Jr alloy coated
with three-layered membrane that consists of KC1, NO-selective
resine and silicone membranes. A positive voltage is applied at the
working electrode, enabling electrochemical oxidation of NO. The
polarographic current is detected by a current-voltage converter
circuit. The system was calibrated in NO donor solution (SNAP),
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as previously described [211, with the relationship between the
current and NO concentration about 0.04 JIM NO per 100 pA. The
working electrode was inserted at a depth of 4.5 to 5.5 mm into the
outer medulla through a Quickcut polyethylene guide piercing the
renal surface about 5 mm from the insertion-site of the laser-
Doppler probe. The reference carbon-fiber electrode was posi-
tioned touching the adjacent renal capsule some 5 mm from the
insertion point of the working electrode.
The proper placement of both laser-Doppler and NO probes
within the outer medulla was confirmed at the conclusion of the
experiment by renal dissection along their tracts.
Analyzing process
On-line recordings of hemodynamic variables and NO elec-
trode current were stored, displayed and analyzed with the use of
a computerized system (MacLab/8; Analog Digital Instruments,
Pty LTD, Castle Hill, NSW, Australia). Mean values for each
determinant were analyzed over 2.5 or 5 minute intervals. All
values are expressed as the percentage of baseline measurements.
Experimental design
Inhibition of NO synthesis affects renal perfusion, oxygenation
and possibly temperature, that could interfere with NO readings.
Therefore, experiments were aimed to to isolate the effects of
changes in renal oxygenation and temperature and to compare
them with the net effect of NOS inhibition.
Effect of NOS inhibition and L-arginine. NOS inhibition is
expected to reduce NO production and is associated with pro-
found decline in renal blood flow and oxygenation [8, 10].
Following the 0.5 to 1 hour baseline recordings required for
stabilization of measurements, rats were intravenously injected
with the NOS inhibitor N° nitro-L-arginine methyl ester HC1
(L-NAME), 10 mg/kg (N = 11) or N'° nitro-L-arginine (NNLA),
10 mg/kg (N = 3), and followed for 15 minutes, until stabilization
of all recordings. Since hemodynamic responses to both agents
and changes in NO readings were comparable, results were
grouped together for convenience.
L-arginine ameliorates renal blood flow [22, 231 and improves
medullary hypoxia induced by NOS inhibitors [10]. Rats that were
pre-treated with NOS inhibitors were injected intravenously with
L-arginine (300 mg/kg, N = 5).
Effect of indomethacin and flirosemide. Indomethacin aggravates
[24] while furosemide ameliorates [25] medullary hypoxia. Rats
pre-treated with NOS inhibitors were administered with indo-
methacin (10 mg/kg, N 5) or furosemide (3 mg/kg, N = 7).
Experiments were done following NOS-inhibition in an attempt to
evaluate the isolated effect of tissue 02 upon NO readings in vivo.
In vitro studies
The electrode was immersed in 100 ml phosphate buffer
solution (PBS, pH 7.0), kept at constant temperature of 37°C. NO
donors were added [S-nitroso-N-acetyl-dl-penicillamine (SNAP),
0.5 mmol/liter or nitroprusside 10 mmol/liter] and the reservoir
was intermittently gassed with 5% 02/95% N2 or 5% CO2/95%
N2. The effect of bubbling by the two gases on the electrode
current was determined also at the absence of NO donors. The
effect of the addition of L-NAME (up to 5 mg/dl) to NO-donor
solution was studied as well.
Indomethacin and the NOS inhibitors L-NAME and NNLA,
purchased from Sigma Chemical Co. (St. Louis, MO, USA), were
05WTh202530
Fig. 1. Effects of NOS inhibition (with L-NAME, N = 11, or NNLA, N =
3; 10mg/kg) upon systemic and renal hemodynamics (A) and medullaty NO
(B) recordings in rats. Five experiments were extended by the administra-
tion of L-arginine (300 mg/kg). Baseline electrode current for these
experiments was an equivalent of 5.2 0.4 ILM NO. Symbols in A are: (•)
blood pressure; (0) renal blood flow. Symbols in B are: (•) medullasy NO;(0) medullary flow. °P < 0.01 versus baseline; #p < 0.02 versus post-NOS
inhibition, by ANOVA.
dissolved in phosphate buffer (pH 7.4) or saline at final concen-
trations of 5, 10 and 2.5 mg/mI, respectively. Furosemide was
diluted in saline to a 1 mg/mI concentration.
Statistics
Values are presented as the means SEM. One-way analysis of
variance was applied for comparisons of repeated measurements,
with Newman-Keuls test used for post-hoc multiple comparisons.
Paired and non-paired Student's t-test was applied for all other
comparisons, and statistical significance was set at P < 0.05.
Results
In vivo studies
Effects of NOS inhibition and L-arginine (Figs. 1 and 2). Follow-
ing the administration of the NOS inhibitors L-NAME or NNLA,
blood pressure rose from 102 4 mm Hg by 25 4% and total
renal and outer medullary blood flows, determined with ultrasonic
and laser-Doppler probes, declined by 21 4% and 39 5%,
respectively (N = 14, P < 0.01), in concordance with previous
L-NAME L-arginine
a)
a)
0)
.0
E0
0)
0
40
30
20
10
0
—10
—20
—30
—40
30
20
10
0
—10
—20
—30
—40
—50
I I
0 5 10 15 20 25 30
Time, minutes
Ch
an
ge
 fr
om
 b
as
eh
ne
, %
 
r!a
ja.
i 
0 
(31
 
0 
(31
 
0 
01
 
00
 0
 
0 
0 
00
 0
 0
 0
 0
 0
0 
0 
0 
0 
0 
I 
I 
I 
I 
I 
QI
 
I 
•
 
I 
Ifl
i 
.
1.
1W
 
-
Iii
 
-
ii 
Heyman et al: Intrarenal nitric oxide monitoring 1621
medullary NO readings increased by 2280 453 pA (14 2%,
P < 0.004; Fig. 2).
From previous studies in the same experimental settings, furo-
semide is known to increase medullary P°2 by nearly 100% [251
due to reduction in oxygen consumption for ionic transport. In the
present work, in NOS-inhibited rats, bolus furosemide sharply
reduced medullary blood flow by 17 4% (P < 0.005). After a
short-term (1 to 5 mm) initial increase, furosemide induced a
protracted decline of NO current of 2532 633 pA (21 4%)
below baseline current (N = 7, P < 0.002; Fig. 2). During all
maneuvers detailed above the renal temperature was stable to
within 0.3°C.
In vitro experiments
When the electrode was bathed ex vivo in NO donor solutions,
the current rose by 20 3% (P < 0.001) when 02 fraction fell
from 5% (equivalent to a P°2 of about 34 mm Hg) to 0%. NO
electrode current rose by 165 57 pA in the SNAP solution (0.5
mmol/liter), and by 773 89 pA in nitroprusside (10 mmol/liter).
Readings were unaffected by 02 at the absence of NO donor, with
the effect of bubbling of both gasses comparably negligible (8 10
and 9 2 pA at 0% and 5% 02). The addition of L-NAME to the
solution at the presence of NO donors had no effect upon NO
electrode current at concentrations up to 5 mg/dl.
Discussion
Indomethacin Furosemide L-arginine
(N=5) (N=7) (N=5)
Fig. 2. Effect of indomethacin (10 mg/kg), furosemide (3 mg/kg) or L-
arginine (300 mg/kg) upon (A) medulla,'y blood flow, (B) medulla,y NO, (C)
renal blood flow, and (D) mean blood pressure in rats pre-treated with NOS
inhibitors. Baseline electrode current for these experiments was an equiv-
alent of 5.0 0.6 ILM NO. P < 0.005 versus baseline, paired t-test.
observations [8, 9, 12]. Continuously monitored outer medullary
NO electrode current, however, did not fall, and in fact rose on the
average by 2350 528 pA or 19 7% from baseline (N = 14, P <
0.01, ANOVA).
Hemodynamic changes produced by NOS inhibition were par-
tially reversed by L-arginine, with some decline in blood pressure
and amelioration of total renal and medullary blood flow. NO
signal paradoxically declined by 2532 633 pA to 88 12% of
baseline (N = 5, P < 0.02 vs. post L-NAME).
Effects of indomethacin and furosemide. From previous studies,
performed under the same experimental conditions, indometha-
cm is known to reduce medullary P°2 from 28 5 to 12 4 mm
Hg [24], in part due to medullary vasoconstriction [26]. In the
present work, in rats pre-treated by NOS inhibitors, while indo-
methacin further reduced medullary blood flow (by 31 4%),
NO electrode current is affected by changes in oxygen content,
since the latter and its reactive species binds with nitric oxide to
produce N02/N03, not sensed by the electrode [21]. This led us
to study whether in vivo physiologic changes of renal parenchymal
oxygen tension might affect the NO electrode current. We hypoth-
esized that the NO current may reciprocally increase during a
reduction in tissue oxygenation, as less NO is being scavenged.
Conversely, the NO current may decline during a rise in tissue
P°2' as the result of enhanced removal of nitric oxide by
conversion to N03. The present observation supports this hy-
pothesis: while the administration of NOS inhibitors was associ-
ated with the well recognized hemodynamic consequences, spe-
cifically a rise in blood pressure and a drop in renal blood flow, a
paradoxical increase rather than a decrease in medullary NO
readings was noted (Fig. 1). Alternative explanations for the
observed rise in NO signal during maneuvers associated with
lowered tissue P°2 include: increased NO synthesis or increased
formation by nitrosothiols; decreased binding of NO to metal
containing proteins, decreased oxidation by superoxide or de-
creased reduction by thiols; other artifacts, such as the production
of a renal substance that interferes with the electrode recording
capabilities.
Several observations suggest an inverse relationship between
NO readings and oxygen tension. NOS inhibition results in
profound decline in renal blood flow and a fall in tissue oxygen
levels, especially at the outer medulla [27]. In this perspective, the
effect of declining parenchymal oxygen content, leaving more
nitric oxide available to the electrode, could overcome the impact
of inhibition of nitric oxide synthesis. L-arginine in large amounts
partially overcomes the NOS inhibition, with rise in nitric oxide
production and reversal of hemodynamic alterations [22, 23]. In
rats pre-treated with NOS inhibitors, the medullary NO electrode
current, which was expected to rise, in fact fell in response to
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L-arginine infusion (Figs. I and 2), in association with ameliora-
tion in tissue blood flow and oxygenation as previously reported
[271. Other experiments were designed to manipulate medullary
oxygenation and were performed in rats pre-treated with NOS
inhibitors, to minimize any effect of NOS activation arid increased
nitric oxide production in response to the various stimuli. Indo-
methacin is known to produce profound medullary hypoxia [24] as
a result of a decrease in medullary blood flow [26] and dis-
inhibition of transport activity by medullary thick ascending limbs
[28]. As with NOS inhibitors, indomethacin administration was
followed by an increase in NO electrode current concomitantly
with the decline in medullary microcirculation (Fig. 2). Furo-
semide markedly increases medullary oxygen tension by the
inhibition of transport activity and ameliorates tissue hypoxia and
hypoxic damage [29—311, despite a decrease in medullary flow
[251. The profound decline in NO readings that closely ensues
may relate to a rise in medullary oxygenation, associated with the
inhibition of metabolic activity.
Wang et al noted an increase in NO electrode current in the
pulmonary vasculature during hypoxia in isolated perfused rat
lung [181. Their observation could also reflect the chemical
interreaction between NO and oxygen or reactive oxygen species
rather than a direct effect upon NO production. Our observations
in the living rat are further supported by the findings ex vivo that
lowering the P°2 in NO donor solutions, from 5% (comparable to
the normal medullary P02 of 34 mm Hg) to 0%, markedly
enhanced the electrode current. In the absence of NO donors,
oxygen deprivation did not change the electrode current,
excluding a direct effect of oxygen. Taken together these
observations are consistent with an inverse relationship be-
tween NO readings and oxygen tension. Nevertheless, the
multiplicity of alternative explanations mentioned above and
the complexity of the biological system does not allow a firm
conclusion about the correct interpretation of the present
observations. Further studies are required to evaluate whether
we describe a mere technical artifact or whether changes in NO
electrode current reflect physiologic effect of tissue oxygen
tension upon nitric oxide bioavailability.
Changes in renal temperature were also found to affect NO
measurements in vivo, with recordings falling by 20% during a
rapid reduction of renal temperature by about 2°C (data not
shown). This is in agreement with previous observations [21],
underscoring the technical importance of renal thermal control.
Another potential pitfall is a direct effect of various substances
upon the electrode behavior. L-NAME hut not other NOS
inhibitors was reported to directly affect the electrode current
[21]. We did not trace such an effect in the bath, in the absence of
cells or tissue, at the presence of NO donors. By contrast, both
L-NAME and NNLA produced adequate reduction in the elec-
trode current during colonic NO recordings in vivo in rats (F.
Karmeli, unpublished data).
In conclusion, this work points out potential pitfalls in the
implementation of renal NO monitoring in vivo by Clark-type
electrodes. While meticulous precaution may prevent changes in
renal temperature that could affect NO readings, stabilization of
tissue oxygenation might be impractical in the living organism.
These findings suggest caution in the interpretation of readings
obtained with this Clark-type NO electrode in tissues with low
oxygen tension, such as the renal medulla. It is also suggested that
tissue hypoxia may augment bioavailability of NO for physiolog-
ical vasodilation.
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